TechTarget

Belkins
TechTarget (Nasdaq: TTGT) is the global leader in purchase intent-driven marketing and sales services that deliver business impact for enterprise technology companies. By creating abundant, high-quality editorial content across more than 140 highly targeted technology-specific websites, TechTarget attracts and nurtures communities of technology buyers researching their companies’ information technology needs. By understanding these buyers’ content consumption behaviors, TechTarget creates the purchase intent insights that fuel efficient and effective marketing and sales activities for clients around the world.

C-Suite On Deck

John A. Steinert, Chief Marketing Officer at TechTarget helps bring the power of purchase intent-driven marketing and sales services to technology companies.

With a strong drive to help customers achieve their business objectives faster and bigger, John and his TechT...

Events

Related News

PHARMACY MARKET

REGIS EXPANDS FACILITIES TO SUPPORT RISING DEMAND FOR U.S.-BASED CUSTOM API PHARMACEUTICAL DEVELOPMENT AND MANUFACTURING

Regis | February 18, 2021

news image

Regis Technologies, Inc. today reported the culmination of a significant extension of their laboratory facilities for the development of dynamic pharmaceutical ingredients (APIs) situated in Morton Grove, Illinois. The extension, which pairs the organization's ability to take on new development projects, is currently completely operational. It expands capacities across Regis' custom pharmaceutical service contributions, including analytical development, process chemistry, solid state che...

Read More

RESEARCH

BIOGNOSYS LAUNCHES NEXT-GENERATION BLOOD BIOMARKER DISCOVERY SOLUTION

Biognosys | November 10, 2021

news image

Biognosys, a leader in proteomics solutions for drug discovery and development, announces the launch of its next-generation blood biomarker discovery solution, which will be offered as a contract research service. The service is designed to help researchers decipher the complexity of the blood proteome and unlock unbiased discoveries for pharma and diagnostics development and precision medicine. The launch will feature a series of events and resources that detail the science and t...

Read More

ZEALAND PHARMA STRENGTHENS EXECUTIVE TEAM WITH NEW U.S. LEADERSHIP

Globe newswire | June 15, 2020

news image

Zealand Pharma, a biotechnology company changing lives with innovative peptide-based medicines, today announced the appointment of Frank Sanders as President of Zealand Pharma U.S. Frank will join Zealand on July 6, 2020. “I am pleased to welcome Frank Sanders to Zealand Pharma, and am confident that he will provide strong and experienced leadership for our U.S. organization,” said Emmanuel Dulac, President and Chief Executive Officer at Zealand Pharma. “Frank has more than 25 ...

Read More

RESEARCH

PFIZER AND BIONTECH NAB COVID-19 VACCINE AUTHORIZATION FROM U.K. FOR FIRST-EVER MARKETED MRNA SHOT

Pfizer | December 03, 2020

news image

The two organizations' BNT162b2 has become the primary COVID-19 immunization permitted in the Western world as medication controllers in the U.K. given out a crisis use approval on Wednesday, in front of choices by the U.S. also, Europe, which are normal soon. For the more extensive immunization world, the Medicines and Healthcare items Regulatory Agency's choice methods the world currently has the principal mRNA shot approved for far reaching use, opening up a fresh out o...

Read More

PHARMACY MARKET

Regis | February 18, 2021

news image

REGIS EXPANDS FACILITIES TO SUPPORT RISING DEMAND FOR U.S.-BASED CUSTOM API PHARMACEUTICAL DEVELOPMENT AND MANUFACTURING

Regis Technologies, Inc. today reported the culmination of a significant extension of their laboratory facilities for the development of dynamic pharmaceutical ingredients (APIs) situated in Morton Grove, Illinois. The extension, which pairs the organization's ability to take on new development projects, is currently completely operational. It expands capacities across Regis' custom pharmaceutical service contributions, including analytical development, process chemistry, solid state che...

Read More

RESEARCH

Biognosys | November 10, 2021

news image

BIOGNOSYS LAUNCHES NEXT-GENERATION BLOOD BIOMARKER DISCOVERY SOLUTION

Biognosys, a leader in proteomics solutions for drug discovery and development, announces the launch of its next-generation blood biomarker discovery solution, which will be offered as a contract research service. The service is designed to help researchers decipher the complexity of the blood proteome and unlock unbiased discoveries for pharma and diagnostics development and precision medicine. The launch will feature a series of events and resources that detail the science and t...

Read More

Globe newswire | June 15, 2020

news image

ZEALAND PHARMA STRENGTHENS EXECUTIVE TEAM WITH NEW U.S. LEADERSHIP

Zealand Pharma, a biotechnology company changing lives with innovative peptide-based medicines, today announced the appointment of Frank Sanders as President of Zealand Pharma U.S. Frank will join Zealand on July 6, 2020. “I am pleased to welcome Frank Sanders to Zealand Pharma, and am confident that he will provide strong and experienced leadership for our U.S. organization,” said Emmanuel Dulac, President and Chief Executive Officer at Zealand Pharma. “Frank has more than 25 ...

Read More

RESEARCH

Pfizer | December 03, 2020

news image

PFIZER AND BIONTECH NAB COVID-19 VACCINE AUTHORIZATION FROM U.K. FOR FIRST-EVER MARKETED MRNA SHOT

The two organizations' BNT162b2 has become the primary COVID-19 immunization permitted in the Western world as medication controllers in the U.K. given out a crisis use approval on Wednesday, in front of choices by the U.S. also, Europe, which are normal soon. For the more extensive immunization world, the Medicines and Healthcare items Regulatory Agency's choice methods the world currently has the principal mRNA shot approved for far reaching use, opening up a fresh out o...

Read More